The global in vivo imaging market is presumed to register a significant CAGR during the forecast period (2017-2023) owing to the increasing prevalence of cancer, asserts Market Research Future (MRFR). In vivo imaging can be referred to the visualization of various life processes in an organism.
In Vivo Imaging Market: Rising healthcare expenditures and increasing prevalence of cancer followed by R&D in the imaging technology for the diagnosis of various types of diseases such as cancer are the major drivers of the market growth
Competitive Analysis by Major Key Players are
Aspect Imaging.,
MR Solutions,
New England Biolabs,
Mediso Ltd.,
MILabs B.V.,
LI-COR, Inc.,
FUJIFILM VisualSonics Inc.,
Biospace Lab S.A.,
Bruker,
and TRIFOIL IMAGING
Industry Segmentation
The global in vivo imaging market has been segmented on the basis of application, end-users, techniques, and region.
By mode of application, the global in vivo imaging market has been segmented into optical imaging, nuclear imaging, and others.
By mode of techniques, the global in vivo imaging market has been segmented into biomarkers based, radioisotopes based, luminescent proteins-based techniques, and others.
By mode of end-users, the global in vivo imaging market has been segmented into imaging centers, hospitals and clinics, research organizations, and others.
Drivers and Restraints Impacting the Market
With the increasing expenditure on healthcare and growing prevalence of cancer, the global market for in vivo imaging is likely to propel during the review period. Research and development activities in the imaging technology for diagnosing several types of chronic diseases such as cancer is further augmenting the market growth. Additionally, the growing incidences of chronic diseases have inflicted a fear among the population has increased the need for frequent checkup, thereby augmenting the demand for in vivo imaging. The increasing number of clinical research organizations and pharmaceutical companies along with rising application of in vivo imaging in real-time data storage, pre-clinical research, and high-resolution modalities are some of the key growth factors of the market.
On the flip side, lack of awareness about in vivo imaging, low expenditure on healthcare in developing countries, and uneven distribution of medical services over regional boundaries are likely to retard the market growth in the coming years.
Industry News
October 2, 2018: A team of scientists at the University of Tsukuba has developed a tool that is capable of imaging the development of atherosclerotic plaque in the body and can follow its progression. This enables the accurate evaluation of drugs in order to treat atherosclerosis and analyze the risk posed by such plaque in an individual.
Regional analysis
The Americas holds the largest market share owing to increasing prevalence of cancer, the presence of developed countries such as the U.S. and Canada in the region.
Europe holds the second largest market share. Factors such as increasing healthcare expenditures, rapid advancements in the healthcare services and technology will boost the market.
Asia Pacific market is expected to grow rapidly due to the presence of developing economies such as India and China, which are adopting new technologies in the medical service sector.
The Middle East & Africa will show the least growth owing the region's low penetrance in the market. Factors such as lack of awareness and low per capita income will restrain the market in Africa. The market will be lead by the countries like Saudi Arabia in the Middle East.
get full report https://www.marketresearchfuture.com/reports/in-vivo-imaging-market-780
Related Reports
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
In-Vivo Imaging Industry Analysis 2019 to 2023The global In-Vivo Imaging Industry is presumed to register a significant CAGR during the forecast period (2017-2023) owing to the increasing prevalence of cancer, asserts Market Research Future (MRFR).
In vivo imaging can be referred to the visualization of various life processes in an organism.Get Free Sample at https://www.marketresearchfuture.com/sample_request/780 National Cancer Institute published in 2016 states that about 1.6 million new cases of cancer were diagnosed in 2010 and the national expenditures for cancer expected to reach USD 156 billion by 2020 from USD 125 billion in 2010Competitive Analysis by Major Key PlayersThe major players operating the global market are Aspect Imaging., MR Solutions, New England Biolabs, Mediso Ltd., MILabs B.V., LI-COR, Inc., FUJIFILM VisualSonics Inc., Biospace Lab S.A., Bruker, and TRIFOIL IMAGINGIndustry SegmentationThe global In-Vivo Imaging Industry has been segmented on the basis of application, end-users, techniques, and region.By mode of application, the global In-Vivo Imaging Industry has been segmented into optical imaging, nuclear imaging, and others.By mode of techniques, the global In-Vivo Imaging Industry has been segmented into biomarkers based, radioisotopes based, luminescent proteins-based techniques, and others.By mode of end-users, the global In-Vivo Imaging Industry has been segmented into imaging centers, hospitals and clinics, research organizations, and others.
On the flip side, lack of awareness about in vivo imaging, low expenditure on healthcare in developing countries, and uneven distribution of medical services over regional boundaries are likely to retard the market growth in the coming years.
Comprehensive Regional AnalysisGeographically, the In-Vivo Imaging Industry span across regions namely, America, Europe, Asia Pacific, and the Middle East and Africa.Among all the regions, America holds the largest market share due to the growing prevalence of chronic diseases such as cancer.
Also, the presence of developed countries like Canada and the U.S. is likely to augment the market growth in this region.Browse Complete Premium Research Report at https://www.marketresearchfuture.com/reports/in-vivo-imaging-market-780Europe is estimated to hold the second position in the market due to factors such as growing expenditure on healthcare.
Moreover, rapid technological advancements in the healthcare services are anticipated to boost the market growth during the assessment period.The Asia Pacific region is considered to grow rapidly during the assessment period owing to the presence of developing economies such as China and India which are adopting the latest technologies in the medical sectors.
Version Control Systems Market Research Report, by Type (Centralized and Distributed), Deployment Type (Cloud and On-Premise), Organization Size (SME and Large Enterprises), Vertical (BFSI, Healthcare, Education, and others) — Global Forecast till 2023 Market ScenarioDistributed version control systems (DVCS) are fast, reliable, and easy to use resulting in providing a complete code database on a developer’s computer.
Furthermore, Market Research Future predicts the maturity of the global version control system market with a CAGR of 11.34% and market value of USD 779.44 million in the year 2023.
The version control system allows application developers to track and compare previous files and sources and ensures monitoring modifications which takes place in the mobile application due to the control system.
Key PlayersThe prominent players in the version control system market are CA Technologies (US), IBM (US), Microsoft (US), Amazon.com (US), Atlassian (Australia), Codice Software (Spain), Canonical Ltd. (UK), CollabNet (US), LogicalDOC (US), and SourceGear LLC (US).Luit Infotech (P) Ltd. (India), Micro Focus (UK), and Perforce Software Inc. (US) are among the other players in the market.
These segments are further sub-segmented into the following:By type, the version control systems market is bifurcated into centralized version control system (CVCS) and distributed version control system (DVCS).By deployment type, this market is segmented into cloud and on-premise.By organization size, the market is segmented into small and medium-sized enterprise and large enterprise.By vertical, the version control systems market is segmented into BFSI, IT and telecom, healthcare, education, retail, and others.By region, North America, Europe, Asia-Pacific, and the rest of the world are the global segments.
The US and Canada are a few countries in the region, leading due to technical advancements and increasing adoption of cloud-based services and solutions.
Global Skin Biopsy Market Driven By The Rising Expenditure On HealthcareAccording to the market research future (MRFR), the global skin biopsy market is expected to record a significant market valuation at a CAGR of 9.4% over the review period.The global market for skin biopsy is expected to grow owing to influential factors such as the rising prevalence of skin cancer, and other skin diseases such as psoriasis, dermatitis, viral skin infections.
Additionally, the increasing demand for minimally invasive medical procedures is expected to fuel the demand for skin biopsy over the evaluation period.
On the other hand, the higher treatment cost of skin diseases is projected to hinder the growth of the global skin biopsy market over the forecast period.Download Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/4650 Skin Biopsy Market Segmental AnalysisThe global Skin Biopsy Market Revenue has been segmented based on type, devices, indication, and end-user.Based on type, the skin biopsy market is segmented into excisional biopsy, incisional biopsy, punch biopsy, and shave biopsy.Based on devices, the skin biopsy market has bee segmented into biopsy curettes and punches, biopsy forceps, biopsy needles, biopsy guns, guidance systems.
Based on indication, the market for skin biopsy has been segmented into actinic keratosis, cancer, dermatitis, psoriasis, skin infection, and others.
The skin infection segment is sub-segmented into basal cell carcinoma, deep fungal infections, melanoma, squamous cell carcinoma, and viral infections.
The demand for technologically advanced medical devices and diagnostic services is also likely to contribute significantly to the skin biopsy market in the region.The Middle East and Africa region are accounted for the smallest market share over the review period, owing to the poor healthcare infrastructure, lack of expenditure, and technological advancements in certain parts of Africa.
Market HighlightsThe Global Phytoestrogen Supplements market is expected to grow at an approximate CAGR of 6.1% during the forecast period, 2018–2023.Phytoestrogens are plant-derived xenoestrogens which are used to address issues associated with the decline of estrogen secretion during menopause.
In recent years, the demands for phytoestrogens have increased owing to the increasing female geriatric population, growing demands for nutraceutical, rising prevalence of acne and increasing awareness regarding women health.
However, risks associated with the consumption and low healthcare expenditure within the middle and low-income countries is estimated to restraint the market growth during the forecast period.Get Free SAmple Copy @ https://www.marketresearchfuture.com/sample_request/6136Regional AnalysisThe Americas dominates the global market for phytoestrogen supplements owing to growing female geriatric population and presence of major market players within the region.
Additionally, the presence of developed economies and healthcare sector within the region fuels the market growth during the forecast period.
In 2017, it was estimated that Europe stood second in the global phytoestrogen supplements market due to increasing prevalence of acne and presence of a well-developed healthcare sector within the region.
On the other hand, the Middle East and Africa holds the least share in the global phytoestrogen supplements market.
The global market is anticipated to grow at a CAGR of 5.2% during the forecast period 2018 to 2023, and is segmented on the basis of product, application, usability, end user, and region.Neuroendoscopy Market OverviewAccording to Market Research Future (MRFR), the global neuroendoscopy market is expected to grow at an approximate CAGR of 5.2% from 2017 to 2023 (forecast period).
Neuroendoscopy is defined as a minimally invasive surgical procedure that is commonly used for tumor removal.
Some of the other benefits of neuroendoscopy include rapid recovery, minimal scarring, and others.
As per the National Institute of Health, the global geriatric population is expected to be more than triple between 2015 and 2050, i.e., it is projected to rise from 126.5 million in 2015 through 446.6 million by 2050.
Nevertheless, the lack of physicians and the rising cost of neuroendoscopy procedures and equipment are projected to inhibit the development of the market during the forecast period.
In 2016, the Association of American Medical Colleges reported that the demand for physicians continued to increase at a higher pace, exceeding the supply.
Market Key Players Teva Pharmaceutical Industries Ltd. (Israel), Becton, Dickinson and Company (U.S.)Corvida Medical (U.S.) ICU Medical Inc. (U.S.) Yukon Medical (U.S.)Equashield LLC (U.S.) The global closed system drug transfer device (CSTD) market size is poised to expand at 19.10% CAGR over the forecast period (2018-2025).The market is driven by the prevalence of cancer cases globally.
CSTDs are required for protecting hospital staff from hazardous drugs and ensuring their safety.
Furthermore, safety guidelines outlined by regulatory bodies for safe handling practices at hospitals and clinics is predicted to augur well for the closed system drug transfer device (CSTD) market.Free sample copy is available @ https://www.marketresearchfuture.com/sample_request/7733Segmentation AnalysisThe closed system drug transfer device (CSTD) market is segmented by type, delivery, and end-user.By type, barrier-type was the largest shareholder in 2017, while the filtration-type held stood second in the global market.
By modes of delivery, closed bag/line access devices accounted for the largest share in the CSTD market (2017).
Among end-users, specialty centers held 70.92% market share in 2017.
This can be linked to high use of chemotherapy drugs by oncology professionals to treat patients suffering from cancer.Regional AnalysisGeographically, the closed system drug transfer device (CSTD) market covers the upcoming trends in Europe, Asia Pacific (APAC), Americas, and the Middle East & Africa (MEA).
